With half the world population as target customers, a market potential of $50 billion by 2025, spurred by almost $1 billion in funding over the last three years, and a positive regulatory environment, female technology (FemTech) is emerging as the next big disruptor in the global health care market, according to Frost & Sullivan. “FemTech” refers to software, diagnostics, products and services that use digital technology to improve women’s health.
Frost & Sullivan identified the following insights on women’s economic power and customer behaviour: Ninety per cent women are primary health care decision makers for their family and key
Frost & Sullivan identified the following insights on women’s economic power and customer behaviour: Ninety per cent women are primary health care decision makers for their family and key
